Von Hippel Lindau (VHL) Mouse Monoclonal Antibody [Clone ID: LBI1E1]

VHL

Pathways in cancer, Renal cell carcinoma, Ubiquitin mediated proteolysis

Full length human recombinant protein of human VHL(NP_000542) produced in HEK293T cell.

VHL

Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]

1 mg/ml

WB 1:4000, IHC 1:150

Pathways in cancer, Renal cell carcinoma, Ubiquitin mediated proteolysis